JP2023540849A5 - - Google Patents
Info
- Publication number
- JP2023540849A5 JP2023540849A5 JP2023505820A JP2023505820A JP2023540849A5 JP 2023540849 A5 JP2023540849 A5 JP 2023540849A5 JP 2023505820 A JP2023505820 A JP 2023505820A JP 2023505820 A JP2023505820 A JP 2023505820A JP 2023540849 A5 JP2023540849 A5 JP 2023540849A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- compound
- formula
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063058630P | 2020-07-30 | 2020-07-30 | |
| US63/058,630 | 2020-07-30 | ||
| PCT/EP2021/071376 WO2022023519A1 (en) | 2020-07-30 | 2021-07-30 | Methods of treatment of trigeminal neuralgia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023540849A JP2023540849A (ja) | 2023-09-27 |
| JP2023540849A5 true JP2023540849A5 (https=) | 2024-08-06 |
Family
ID=77520687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023505820A Pending JP2023540849A (ja) | 2020-07-30 | 2021-07-30 | 三叉神経痛の治療方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20230172922A1 (https=) |
| EP (1) | EP4188370A1 (https=) |
| JP (1) | JP2023540849A (https=) |
| KR (1) | KR20230047132A (https=) |
| CN (1) | CN115989024A (https=) |
| AR (1) | AR123108A1 (https=) |
| AU (1) | AU2021316675A1 (https=) |
| BR (1) | BR112023001621A2 (https=) |
| CA (1) | CA3182457A1 (https=) |
| CL (1) | CL2023000261A1 (https=) |
| IL (1) | IL300124A (https=) |
| MX (1) | MX2023001288A (https=) |
| PH (1) | PH12023550204A1 (https=) |
| TW (1) | TW202220649A (https=) |
| WO (1) | WO2022023519A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100548299C (zh) * | 2001-01-05 | 2009-10-14 | 伊莱利利公司 | 兴奋性氨基酸受体拮抗剂 |
| UA80888C2 (en) | 2003-06-05 | 2007-11-12 | Hoffmann La Roche | Imidazole derivatives as glutmate receptor antagonists |
| NZ551253A (en) * | 2004-06-01 | 2010-07-30 | Hoffmann La Roche | Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as MGLU5 receptor antagonists |
| MY148217A (en) * | 2006-12-21 | 2013-03-29 | Hoffmann La Roche | Polymorphs of a mglur5 receptor antagonist |
| US8211882B2 (en) * | 2008-03-08 | 2012-07-03 | Richard Delarey Wood | Glutamate receptor modulators and therapeutic agents |
| WO2011035209A1 (en) * | 2009-09-17 | 2011-03-24 | Vanderbilt Universtiy | Substituted benzamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
-
2021
- 2021-07-30 BR BR112023001621A patent/BR112023001621A2/pt unknown
- 2021-07-30 KR KR1020237006497A patent/KR20230047132A/ko active Pending
- 2021-07-30 MX MX2023001288A patent/MX2023001288A/es unknown
- 2021-07-30 CN CN202180049062.XA patent/CN115989024A/zh active Pending
- 2021-07-30 IL IL300124A patent/IL300124A/en unknown
- 2021-07-30 JP JP2023505820A patent/JP2023540849A/ja active Pending
- 2021-07-30 AR ARP210102142A patent/AR123108A1/es unknown
- 2021-07-30 TW TW110128158A patent/TW202220649A/zh unknown
- 2021-07-30 CA CA3182457A patent/CA3182457A1/en active Pending
- 2021-07-30 PH PH1/2023/550204A patent/PH12023550204A1/en unknown
- 2021-07-30 WO PCT/EP2021/071376 patent/WO2022023519A1/en not_active Ceased
- 2021-07-30 EP EP21762351.1A patent/EP4188370A1/en active Pending
- 2021-07-30 AU AU2021316675A patent/AU2021316675A1/en active Pending
-
2023
- 2023-01-26 CL CL2023000261A patent/CL2023000261A1/es unknown
- 2023-01-27 US US18/102,532 patent/US20230172922A1/en not_active Abandoned
-
2025
- 2025-07-18 US US19/273,884 patent/US20250345320A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2672575C2 (ru) | Лечение рака головного мозга | |
| KR102425226B1 (ko) | Jak 저해제를 포함하는 제약 조성물 | |
| JP2022502500A5 (https=) | ||
| FI3856341T3 (fi) | (s)-1-(4-fluorifenyyli)-1-(2-(4-(6-(1-metyyli-1h-pyratsol-4-yyli)pyrrolo[2,1-f][1,2,4]triatsin-4-yyli)piperatsinyyli)pyrimidin-5-yyli)etaani-1-amiinin kidemuotoja ja valmistusmenetelmiä | |
| JPH05213741A (ja) | デプレニル／ｌ−ドーパ／カルビドーパ含有の医薬組成物 | |
| IL224230A (en) | Compositions containing nalbupines and their uses | |
| WO2013063263A1 (en) | Pharmaceutical compositions for treating pain | |
| EA034992B1 (ru) | Комбинации лекарственных средств для лечения множественной миеломы | |
| CA2600510A1 (en) | Crystal forms of an imidazole derivative | |
| JP2022535893A (ja) | 放出調節製剤およびその使用 | |
| JP2021530543A5 (https=) | ||
| CN103585098A (zh) | 普瑞巴林控释制剂及其制备方法 | |
| JP2023528895A5 (https=) | ||
| JP2023540849A5 (https=) | ||
| JP2022518288A5 (https=) | ||
| JP2018140987A5 (https=) | ||
| KR20080017296A (ko) | 면역 조절제 활성을 갖는 화합물 | |
| JP2021517115A (ja) | ポルマコキシブ及びプレガバリンを含む疼痛治療用薬剤学的組成物 | |
| CN110279691B (zh) | 一种外科术后护理镇痛药物及其用途 | |
| WO2013115740A1 (en) | Synergisctic combination comprising a meglitinide derivative and lipoic acid | |
| WO2013169218A1 (en) | Pharmaceutical compositions of s-etodolac | |
| CN104117065B (zh) | 一种基于青藤碱的用于镇痛的药物组合产品 | |
| IL300124A (en) | Methods for treating nerve pain related to the trigeminal nerve | |
| TWI882128B (zh) | 紫質症之預防或治療劑 | |
| US20250213503A1 (en) | Treatment of cancer with s1p receptor agonists |